These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23625299)

  • 1. Impact of ischemia and scar on therapeutic benefit of myocardial revascularization.
    Hachamovitch R
    Herz; 2013 Jun; 38(4):344-9. PubMed ID: 23625299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates.
    Reynolds HR; Picard MH; Hochman JS
    Circ Cardiovasc Imaging; 2015 May; 8(5):discussion p 9. PubMed ID: 25977302
    [No Abstract]   [Full Text] [Related]  

  • 4. Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease effectively identifies revascularization candidates.
    Hachamovitch R
    Circ Cardiovasc Imaging; 2015 May; 8(5):discussion p 8. PubMed ID: 25977301
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial Ischemia in the Management of Chronic Coronary Artery Disease: Past and Present.
    Gibbons RJ
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011615. PubMed ID: 33455408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hybrid imaging in diagnostics and therapy of chronic myocardial ischemia. Clinical value].
    Dörr R; Kadalie CT; Franke WG; Gutberlet M
    Herz; 2013 Jun; 38(4):367-75. PubMed ID: 23604108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and therapy of chronic myocardial ischemia. Role of cardiac magnetic resonance imaging].
    de Waha S; Eitel I; Desch S; Fuernau G; Lurz P; Schuler G; Thiele H
    Herz; 2013 Jun; 38(4):350-8. PubMed ID: 23604110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Shaw LJ; Cerqueira MD; Brooks MM; Althouse AD; Sansing VV; Beller GA; Pop-Busui R; Taillefer R; Chaitman BR; Gibbons RJ; Heo J; Iskandrian AE
    J Nucl Cardiol; 2012 Aug; 19(4):658-69. PubMed ID: 22527794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of J-ACCESS 4: prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease.
    Nanasato M; Nakajima K; Fujita H; Zen K; Kohsaka S; Hashimoto A; Moroi M; Fukuzawa S; Chikamori T; Nishimura S; Yamashina A; Kusuoka H; Hirayama A; Nishimura T
    J Cardiol; 2014 Feb; 63(2):159-64. PubMed ID: 24012330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease: J-ACCESS 4 study.
    Nanasato M; Matsumoto N; Nakajima K; Chikamori T; Moroi M; Takehana K; Momose M; Nishina H; Kasai T; Yoda S; Kiso K; Yamamoto H; Nishimura S; Yamashina A; Kusuoka H; Hirayama A; Nishimura T
    Int J Cardiol; 2018 Sep; 267():202-207. PubMed ID: 29859707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of the BARI 2D and COURAGE trials: overview.
    Brooks MM; Boden WE; Frye RL
    Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications and Debates on the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches Trial.
    Saito Y; Nishi T; Saito K; Kitahara H; Kawase Y; Matsuo H; Kobayashi Y
    Cardiol Rev; 2022 Sep-Oct 01; 30(5):234-240. PubMed ID: 33758121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization.
    Aldweib N; Negishi K; Hachamovitch R; Jaber WA; Seicean S; Marwick TH
    J Am Coll Cardiol; 2013 Apr; 61(15):1616-23. PubMed ID: 23500275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.
    Hachamovitch R; Rozanski A; Shaw LJ; Stone GW; Thomson LE; Friedman JD; Hayes SW; Cohen I; Germano G; Berman DS
    Eur Heart J; 2011 Apr; 32(8):1012-24. PubMed ID: 21258084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Barsness GW; Gersh BJ; Brooks MM; Frye RL;
    Am J Cardiol; 2006 Jun; 97(12A):31G-40G. PubMed ID: 16813736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.